Patent details
LUC00251
Product Name:
Diroximel fumarate
Basic Information
- Publication number:
- LUC00251
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP147678924
- Legal Status:
- Inactive
- Application number:
- LUC00251
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- EU/1/21/1585
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 16/11/2021
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- 68066
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 20/09/2021
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Switzerland (CH)
Dates
- Filing date:
- 16/03/2022
- First Marketing Authorization date:
- 20/09/2021
- Grant date:
- 03/02/2025
- Activation date:
- Publication date:
- 16/03/2022
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 20/09/2036
- SPC Extension Expiration:
- 20/09/2036
- Rejection date:
- Withdrawal date:
Owner
- From:
- 16/03/2022
-
-
- Name:
- Alkermes Pharma Ireland Limited
- Address:
- Connaught House
1 Burlington Road, Dublin 4, Ireland (IE)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 16/03/2022
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2022/05
- Publication date:
- 01/04/2022
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 31/03/2034
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-